Pfizer Inc. ( (PFE) ) is reportedly planning to sell its consumer healthcare business in an auction next month, two unnamed sources close to the matter told Reuters.
The business handles everything from everyday headache medications to cold remedies to digestive health supplements. A sale could happen for over $15 billion, insiders said. The unit had sales of $3.4 billion in 2016.
GlaxoSmithKline plc ( (GSK) ) and Reckitt Benckiser Group Plc ( (RBGLY) ) are reportedly considering making offers to buy the unit. Pfizer had said earlier this month that it would consider selling the consumer healthcare business, but did not offer a timeline.
Pfizer is perhaps best known for making viagra. Did you know Pfizer also made these popular products?
Watch More with TheStreet:
- Jim Cramer Reveals What to Watch in Alphabet's Earnings
- Apple's Former CEO Perfectly Explains Why Tech Giant Can't be a True Innovator
- America's Love for Pumpkins by the Numbers: Video
- What You're Seeing With Cord-Cutting Is Just the Tip of the Iceberg: Akamai CEO